The US stock selloff, BYD's win against Tesla, and the astronauts' return |
Finimize

Hi Reader, here's what you need to know for March 19th in 3:08 minutes.

  1. Investors ditched US stocks, fearing the end of America’s decade-long dominance
  2. Palantir’s high-flying stock is so pricey, even the brave should be worried – Read Now
  3. BYD unveiled a charger that can juice up an EV in five minutes flat – and the Chinese carmaker’s stock sped up, leaving Tesla at the plug

🍸 Finimized over a vermouth at Cafe Con Leche in San Sebastián, Spain (☁️13°C/56°F)

U(SA)-Turn
U(SA)-Turn

What’s going on here?

Bank of America’s latest fund manager survey showed that investors slashed their US stock allocations in March – by a record 40 percentage points.

What does this mean?

Just a month ago, fund managers had high hopes for US stocks. But with a seemingly endless stream of potential tariffs and policy changes flooding out of the Oval Office, folks aren’t so upbeat anymore. Nearly 70% of surveyed fund managers now think the post-election rally – which saw the S&P 500 and Nasdaq reach record highs – has run its course, believing that “US exceptionalism” has peaked.

Why should I care?

For markets: Investors are seeing… euro signs.

With US stocks expected to fall short of their self-inflicted high bar, fund managers are backing Europe’s contenders instead. In their droves too, with Germany – the region’s biggest economy – attracting the most attention. That’s largely because the country’s politicians have pledged to spend more on defense and infrastructure, with European companies expected to benefit from the splurge. In fact, a key indicator showed that investors were more optimistic about Germany in March than at any time since early 2022. Combine those projections with Europe’s relatively cheap stock prices and low interest rates, and you can see why investors have replaced their American dreams with European fantasies.

Zooming in: How the turntables…

Stateside stocks have outdone the rest of the world’s offerings for over a decade, justifying their stomach-turning prices. And while forecasts for the US economy are falling from high to moderate, they’re moving in the opposite direction elsewhere – including both Europe and China. That’s making investors rethink their long-held beliefs. In the US, tried-and-true value and defensive stocks have outperformed high-flying growth ones by around 10% this year, while European indexes have beaten American ones by some 20% – a departure from the norm all around.

Copy to share story: https://app.finimize.com/content/usa-turn

🙋 Ask a question

TODAY'S INSIGHT

Palantir’s High-Flying Stock Is So Expensive It Doesn’t Make Any Sense

Carl Hazeley

Palantir’s High-Flying Stock Is So Expensive It Doesn’t Make Any Sense

Palantir – the secretive US tech giant – has a buzzy, but very expensive stock. I’ve looked closely at the business and its valuation, but I can’t justify Palantir’s share price.

And I’m not alone: in the past year, no company executives have bought shares in this firm. Plenty have sold, though.

In fact, as a group, they’ve dumped $3 billion worth of the stock, selling much of that to retail investors – perhaps including you.

Now, it might seem like you’re onto something good, after the stock’s run-up last year – but, frankly, I’m worried you’re headed for a world of hurt.

That’s today’s Research: what Palantir does, what it should earn, its current valuation – and what all of that should tell you as an investor.

Read or listen to the Research here

Shut Up And Drive
Shut Up And Drive

What’s going on here?

BYD revealed an EV battery system that can charge a car in the time it takes to fill up a tank, silencing both skeptics and those who “don’t have time” for electric charging in one fell swoop.

What does this mean?

BYD’s new “super e-platform” can deliver 1,000 kilowatts of power in five minutes flat – enough for a 249-mile joyride. That’s thanks to a combination of flash-charging batteries, a high-speed motor, and next-generation power chips. BYD’s new tech is nearly four times faster than Tesla’s current iteration, making it – by far – the fastest EV charging system on the planet. And with BYD planning to roll out over 4,000 of them across China, investors sent the company’s stock up 4% to a record high.

Why should I care?

Zooming in: BYD giveth cost savings, then it taketh away.

BYD has stolen customers from competitors by producing budget-friendly models. And now that it can pair that with unrivaled charging speeds, the Chinese company could grow its market share outside of its home turf. But while the new systems might nix the charging anxiety that prevents prospective buyers from pulling the trigger, they might create some new, different obstacles. Power grids may struggle to keep up with all that super-fast charging, and it could cost manufacturers – and in turn, consumers – to upgrade EVs in order to use the tech.

The bigger picture: Ship China the gold medal.

The US and Europe might have rolled out tariffs in a bid to stop China from running away with the lead, but the likes of BYD and DeepSeek look to be helping the country speed ahead anyway. Chinese carmakers are beating global brands everywhere from Brazil to South Korea. And while Tesla still holds pole position in the charging ecosystem, it sure seems as though BYD’s super e-platform is about to change that.

Copy to share story: https://app.finimize.com/content/shut-up-and-drive

🙋 Ask a question

QUOTE OF THE DAY

"The true delight is in the finding out rather than in the knowing."

– Isaac Asimov (an American writer and professor)
Tweet this

* SPONSORED BY BIOSTEM
BSEM

Think of the tech industry, but with a touch of Scrubs about it

Successful medicinal solutions can be as money-making as they are world-changing.

With high barriers to entry in this industry, the winning formulas can win serious market share. Case in point: the recent weight-loss drug boom, where only a couple of firms captured most of the attention.

Biostem (OTC:BSEM) is developing cutting-edge regenerative medicine products – scientific treatments that make cells regenerate, so humans can self-heal their wounds.

You might think that sounds like sci-fi, but the Biostem’s revenue is as real as can be: the company brought in over $300 million last year, and its preliminary takings from just last quarter is $102 million.

With both trials and revenue on track, Biostem seems ready for the main stage: it’s filed with the SEC, an important step toward listing on the Nasdaq stock exchange.

Biostem’s share price target might be $32.50 for now, but with a potential listing in the works, the MedTech company might not be an under-the-radar opportunity for long.

Find Out More

This content is for US investors only, if you are not a US investor please ignore this content. This content is a paid advertisement for BioStem Technologies, Inc from Sideways Frequency and Finimize. This is not Finimize editorial content. Finimize received a fixed fee from Sideways Frequency for producing, hosting and promoting this content via 4 email sends on behalf of BioStem Technologies, Inc, totalling $10,000. Other than the compensation received for this service, Finimize and its principals are not affiliated with either Sideways Frequency or BioStem Technologies, Inc. Finimize and its principals have no ownership in BioStem Technologies, Inc.

The content on this page should not be taken as advice, an endorsement, or a recommendation from Finimize and its principals to buy or sell any security. Finimize and its principals have not evaluated the accuracy of any claims made on this page. Finimize and its principals recommend that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky and capital is at risk. Past performance is not indicative of future results.

When you support our sponsors, you support us. Thanks for that.

If you want your brand featured here, get in touch.

🎯 On Our Radar

1. Nine months in, nine months out. The Boeing Starliner astronauts are finally headed back to Earth.

2. Don’t leave your options to chance. Master two powerful strategies that can give your portfolio a serious edge.

3. Rules are made to be broken. OpenAI and Google want access to everything – whether they own it or not.

4. Build a portfolio that stands the test of time. See the key steps to long-term success with expert insights.

5. Respect the sauce. Here’s why Mickey 17 is obsessed with slurpy stuff.

🌍 Finimize Live

🤩 Grab your tickets...

🚀 The Rise Of Cryptocurrency In 2025: March 24th

🙌 Your Guide To Flexible ISAs*: April 8th

🤠 How The Smartest Investors Spot Early Crypto Gems: April 15th

*Designed for UK investors

Thanks for reading Reader. If you liked today’s brief, we’d love for you to share it with a friend – here’s a link: Share this email

You stay classy, Reader 😉

Any thoughts on today’s email? Give feedback

Want to advertise with us? Get in touch

Image credits: Midjourney | Midjourney

Preferences:

Update your email or change preferences

View in browser

Unsubscribe from all Finimize Emails

Crafted by Finimize Ltd. | 280 Bishopsgate, London, EC2M 4AG

All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2024

View Online

When you support our sponsors, you support us. Thanks for that.

.